Emel A. P.
- Country
- Germany
- Department
- Dept Of Children and Adolescents
Research Overview
- Efficacy and Safety of Deucrictibant for Prophylaxis and On-demand Treatment of Angioedema Attacks in Adults with Acquired Angioedema due to C1 Inhibitor Deficiency
- Evaluation of Long-Term Safety of Oral Deucrictibant (PHA-022121) for Acute Hereditary Angioedema Attacks in C1-Inhibitor Deficient Patients
- A Phase 3 Open-label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema in Pediatric Subjects 2 to 11 Years of Age
Data & Insights
Has run more than one trial at 57 of 76 partner sites.
Specializations
Hereditary Angioedema Management
This investigator specializes in the treatment and research of hereditary angioedema (HAE), with particular focus on both prophylactic approaches and acute attack management. Their work encompasses innovative therapeutic strategies for Type I and Type II C1-Inhibitor deficiency.
- Prophylactic Treatment Development
- Acute Attack Management
- Long-term Disease Control
The research extends to various treatment modalities including oral medications and subcutaneous therapeutics.
Pediatric HAE Research
The investigator conducts specialized research in pediatric HAE treatment, focusing on age-specific therapeutic approaches for young patients aged 2-12 years. Their work includes evaluation of various treatment formulations adapted for pediatric populations.
- Pediatric Drug Safety Studies
- Age-Appropriate Dosing
- Child-Specific Treatment Protocols
Emphasis is placed on developing safe and effective treatment options for young HAE patients.
Novel Therapeutic Approaches
The investigator explores innovative therapeutic compounds for HAE treatment, including extended-release formulations and novel molecular entities. Their research encompasses both prophylactic and on-demand treatment strategies.
- Extended-Release Medications
- New Molecular Entities
- Treatment Optimization Studies
Research includes evaluation of multiple administration routes and dosing regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.